Ultrastructural and immunocytochemical evidence that an incompetent blood-brain barrier is related to the pathophysiology of cavernous malformations - PubMed (original) (raw)
Ultrastructural and immunocytochemical evidence that an incompetent blood-brain barrier is related to the pathophysiology of cavernous malformations
R E Clatterbuck et al. J Neurol Neurosurg Psychiatry. 2001 Aug.
Abstract
Objectives: Cerebral cavernous malformations are linked to mutations of the KRIT1 gene at the CCM1 locus and to mutations at two other loci, CCM2 and CCM3, for which genes are not yet identified. There is little information regarding the function of KRIT1. Histological and immunocytochemical analysis of cavernous malformations have not shed much light on their pathophysiology.
Methods: Morphological analysis of cavernous malformations was extended to the ultrastructural level by examining lesions from two patients by immunocytochemistry and electron microscopy.
Results: The lesions consisted of endothelial lined vascular sinusoids embedded in a collagen matrix. Nuclei belonging to cells distinct from endothelial cells were rare. The basal lamina of the endothelial cells consisted focally of multiple layers. No tight junctions at endothelial cell interfaces were found; however, several examined endothelial cell interfaces demonstrated apparent gaps between endothelial cell processes where basal lamina was exposed directly to the lumen of the sinusoids. Heavy hemosiderin deposits were found underlying the vascular channels within microns of the basal lamina without evidence of disrupted vessels. No astrocytic foot processes were seen within lesions. Glial fibrillary acidic protein immunocytochemistry confirmed that astrocyte processes stopped at the border of the lesions.
Conclusions: The absence of blood-brain barrier components may lead to leakage of red blood cells into these lesions and the surrounding brain in the absence of major haemorrhage, thus accounting for the propensity of cavernous malformations to cause seizures. These data also raise the possibility that KRIT1 plays a part in the formation of endothelial cell junctions and expression of a mature vascular phenotype.
Similar articles
- Ultrastructural analysis of vascular features in cerebral cavernous malformations.
Tanriover G, Sozen B, Seker A, Kilic T, Gunel M, Demir N. Tanriover G, et al. Clin Neurol Neurosurg. 2013 Apr;115(4):438-44. doi: 10.1016/j.clineuro.2012.06.023. Epub 2012 Jul 7. Clin Neurol Neurosurg. 2013. PMID: 22776801 - A Novel KRIT1/CCM1 Gene Insertion Mutation Associated with Cerebral Cavernous Malformations in a Chinese Family.
Wang H, Pan Y, Zhang Z, Li X, Xu Z, Suo Y, Li W, Wang Y. Wang H, et al. J Mol Neurosci. 2017 Feb;61(2):221-226. doi: 10.1007/s12031-017-0881-5. Epub 2017 Feb 3. J Mol Neurosci. 2017. PMID: 28160210 - High-throughput sequencing of the entire genomic regions of CCM1/KRIT1, CCM2 and CCM3/PDCD10 to search for pathogenic deep-intronic splice mutations in cerebral cavernous malformations.
Rath M, Jenssen SE, Schwefel K, Spiegler S, Kleimeier D, Sperling C, Kaderali L, Felbor U. Rath M, et al. Eur J Med Genet. 2017 Sep;60(9):479-484. doi: 10.1016/j.ejmg.2017.06.007. Epub 2017 Jun 20. Eur J Med Genet. 2017. PMID: 28645800 - Pathology of cavernous malformations.
Cox EM, Bambakidis NC, Cohen ML. Cox EM, et al. Handb Clin Neurol. 2017;143:267-277. doi: 10.1016/B978-0-444-63640-9.00025-4. Handb Clin Neurol. 2017. PMID: 28552149 Review. - Cerebral cavernous malformations: from CCM genes to endothelial cell homeostasis.
Fischer A, Zalvide J, Faurobert E, Albiges-Rizo C, Tournier-Lasserve E. Fischer A, et al. Trends Mol Med. 2013 May;19(5):302-8. doi: 10.1016/j.molmed.2013.02.004. Epub 2013 Mar 15. Trends Mol Med. 2013. PMID: 23506982 Review.
Cited by
- Microangiopathy in the cerebellum of patients with mitochondrial DNA disease.
Lax NZ, Pienaar IS, Reeve AK, Hepplewhite PD, Jaros E, Taylor RW, Kalaria RN, Turnbull DM. Lax NZ, et al. Brain. 2012 Jun;135(Pt 6):1736-50. doi: 10.1093/brain/aws110. Epub 2012 May 9. Brain. 2012. PMID: 22577219 Free PMC article. - Recent insights into cerebral cavernous malformations: animal models of CCM and the human phenotype.
Chan AC, Li DY, Berg MJ, Whitehead KJ. Chan AC, et al. FEBS J. 2010 Mar;277(5):1076-83. doi: 10.1111/j.1742-4658.2009.07536.x. Epub 2010 Jan 22. FEBS J. 2010. PMID: 20096037 Free PMC article. Review. - NOGOB receptor deficiency increases cerebrovascular permeability and hemorrhage via impairing histone acetylation-mediated CCM1/2 expression.
Fang Z, Sun X, Wang X, Ma J, Palaia T, Rana U, Miao B, Ragolia L, Hu W, Miao QR. Fang Z, et al. J Clin Invest. 2022 May 2;132(9):e151382. doi: 10.1172/JCI151382. J Clin Invest. 2022. PMID: 35316220 Free PMC article. - Significance of perilesional T1 hyperintense areas in the differential diagnosis of primary adult-type diffuse glioma: A case report.
Yamano A, Yanaka K, Onuma K, Nakamura K, Takahashi N, Kohzuki H, Sakamoto N, Matsuda M, Ishikawa E. Yamano A, et al. Radiol Case Rep. 2023 Jul 22;18(10):3448-3452. doi: 10.1016/j.radcr.2023.07.023. eCollection 2023 Oct. Radiol Case Rep. 2023. PMID: 37502482 Free PMC article. - The cerebral cavernous malformation signaling pathway promotes vascular integrity via Rho GTPases.
Whitehead KJ, Chan AC, Navankasattusas S, Koh W, London NR, Ling J, Mayo AH, Drakos SG, Jones CA, Zhu W, Marchuk DA, Davis GE, Li DY. Whitehead KJ, et al. Nat Med. 2009 Feb;15(2):177-84. doi: 10.1038/nm.1911. Epub 2009 Jan 18. Nat Med. 2009. PMID: 19151728 Free PMC article.
References
- Hum Mol Genet. 1999 Nov;8(12):2325-33 - PubMed
- Arch Ophthalmol. 1979 Jun;97(6):1144-53 - PubMed
- Arch Ophthalmol. 1984 Mar;102(3):413-8 - PubMed
- J Neurovirol. 1999 Dec;5(6):556-69 - PubMed
- Neurosurgery. 1993 Aug;33(2):179-88; discussion 188 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources